{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:36:02Z","timestamp":1783398962561,"version":"3.54.6"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41388-018-0491-x","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T08:16:58Z","timestamp":1536308218000},"page":"1038-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome"],"prefix":"10.1038","volume":"38","author":[{"given":"Merav D.","family":"Shmueli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limor","family":"Levy-Kanfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esraa","family":"Haj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Gazit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"491_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15586\/jkcvhl.2017.88","volume":"4","author":"N Varshney","year":"2017","unstructured":"Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS. A review of Von Hippel-Lindau syndrome. J Kidney Cancer VHL. 2017;4:20\u20139.","journal-title":"J Kidney Cancer VHL"},{"key":"491_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/onc.2017.338","volume":"37","author":"D Tarade","year":"2018","unstructured":"Tarade D, Ohh M. The HIF and other quandaries in VHL disease. Oncogene. 2018;37:139\u201347.","journal-title":"Oncogene"},{"key":"491_CR3","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"HE Ryan","year":"1998","unstructured":"Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998;17:3005\u201315.","journal-title":"EMBO J"},{"key":"491_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0092-8674(00)80098-7","volume":"86","author":"C Bai","year":"1996","unstructured":"Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW, et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell. 1996;86:263\u201374.","journal-title":"Cell"},{"key":"491_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1172\/JCI8161","volume":"104","author":"M Ohh","year":"1999","unstructured":"Ohh M, Takagi Y, Aso T, Stebbins CE, Pavletich NP, Zbar B, et al. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. J Clin Invest. 1999;104:1583\u201391.","journal-title":"J Clin Invest"},{"key":"491_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 2015;15:55\u201364.","journal-title":"Nat Rev Cancer"},{"key":"491_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271\u20135.","journal-title":"Nature"},{"key":"491_CR8","doi-asserted-by":"publisher","first-page":"25733","DOI":"10.1074\/jbc.M002740200","volume":"275","author":"ME Cockman","year":"2000","unstructured":"Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem. 2000;275:25733\u201341.","journal-title":"J Biol Chem"},{"key":"491_CR9","doi-asserted-by":"publisher","first-page":"10430","DOI":"10.1073\/pnas.190332597","volume":"97","author":"T Kamura","year":"2000","unstructured":"Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, Conaway JW. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA. 2000;97:10430\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"491_CR10","doi-asserted-by":"publisher","first-page":"38183","DOI":"10.1074\/jbc.M302244200","volume":"278","author":"G D\u2019Angelo","year":"2003","unstructured":"D\u2019Angelo G, Duplan E, Boyer N, Vigne P, Frelin C. Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem. 2003;278:38183\u20137.","journal-title":"J Biol Chem"},{"key":"491_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, et al. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2000;2:423\u20137.","journal-title":"Nat Cell Biol"},{"key":"491_CR12","doi-asserted-by":"publisher","first-page":"7985","DOI":"10.1074\/jbc.M413160200","volume":"280","author":"F Miller","year":"2005","unstructured":"Miller F, Kentsis A, Osman R, Pan ZQ. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex. J Biol Chem. 2005;280:7985\u201396.","journal-title":"J Biol Chem"},{"key":"491_CR13","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","volume":"22","author":"E Berra","year":"2003","unstructured":"Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 2003;22:4082\u201390.","journal-title":"EMBO J"},{"key":"491_CR14","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1073\/pnas.181341498","volume":"98","author":"F Yu","year":"2001","unstructured":"Yu F, White SB, Zhao Q, Lee FS. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA. 2001;98:9630\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"491_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468\u201372.","journal-title":"Science"},{"key":"491_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464\u20138.","journal-title":"Science"},{"key":"491_CR17","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP. Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science. 2002;296:1886\u20139.","journal-title":"Science"},{"key":"491_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep31128","volume":"6","author":"F Tabaro","year":"2016","unstructured":"Tabaro F, Minervini G, Sundus F, Quaglia F, Leonardi E, Piovesan D, et al. VHLdb: a database of von Hippel-Lindau protein interactors and mutations. Sci Rep. 2016;6:31128.","journal-title":"Sci Rep"},{"key":"491_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/nar\/26.1.256","volume":"26","author":"C Beroud","year":"1998","unstructured":"Beroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C. Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res. 1998;26:256\u20138.","journal-title":"Nucleic Acids Res"},{"key":"491_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins CE, Kaelin WG Jr, Pavletich NP. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science. 1999;284:455\u201361.","journal-title":"Science"},{"key":"491_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.onc.1209062","volume":"25","author":"K Knauth","year":"2006","unstructured":"Knauth K, Bex C, Jemth P, Buchberger A. Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions. Oncogene. 2006;25:370\u20137.","journal-title":"Oncogene"},{"key":"491_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066333","volume":"8","author":"MD Shmueli","year":"2013","unstructured":"Shmueli MD, Schnaider L, Rosenblum D, Herzog G, Gazit E, Segal D. Structural insights into the folding defects of oncogenic pVHL lead to correction of its function in vitro. PLoS ONE. 2013;8:e66333","journal-title":"PLoS ONE"},{"key":"491_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-229","volume":"9","author":"V Bangiyeva","year":"2009","unstructured":"Bangiyeva V, Rosenbloom A, Alexander AE, Isanova B, Popko T, Schoenfeld AR. Differences in regulation of tight junctions and cell morphology between VHL mutations from disease subtypes. BMC Cancer. 2009;9:229.","journal-title":"BMC Cancer"},{"key":"491_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109864","volume":"9","author":"MD Shmueli","year":"2014","unstructured":"Shmueli MD, Schnaider L, Herzog G, Gazit E, Segal D. Computational and experimental characterization of dVHL establish a Drosophila model of VHL syndrome. PLoS ONE. 2014;9:e109864","journal-title":"PLoS ONE"},{"key":"491_CR25","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1242\/dev.042804","volume":"137","author":"S Duchi","year":"2010","unstructured":"Duchi S, Fagnocchi L, Cavaliere V, Hsouna A, Gargiulo G, Hsu T. Drosophila VHL tumor-suppressor gene regulates epithelial morphogenesis by promoting microtubule and aPKC stability. Development. 2010;137:1493\u2013503.","journal-title":"Development"},{"key":"491_CR26","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1128\/MCB.01578-09","volume":"30","author":"A Hsouna","year":"2010","unstructured":"Hsouna A, Nallamothu G, Kose N, Guinea M, Dammai V, Hsu T. Drosophila von Hippel-Lindau tumor suppressor gene function in epithelial tubule morphogenesis. Mol Cell Biol. 2010;30:3779\u201394.","journal-title":"Mol Cell Biol"},{"key":"491_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/iub.406","volume":"62","author":"SH Khan","year":"2010","unstructured":"Khan SH, Ahmad N, Ahmad F, Kumar R. Naturally occurring organic osmolytes: from cell physiology to disease prevention. IUBMB Life. 2010;62:891\u20135.","journal-title":"IUBMB Life"},{"key":"491_CR28","doi-asserted-by":"publisher","first-page":"054902","DOI":"10.1063\/1.3469790","volume":"133","author":"J Li","year":"2010","unstructured":"Li J, Garg M, Shah D, Rajagopalan R. Solubilization of aromatic and hydrophobic moieties by arginine in aqueous solutions. J Chem Phys. 2010;133:054902.","journal-title":"J Chem Phys"},{"key":"491_CR29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","volume":"15","author":"GL Semenza","year":"1999","unstructured":"Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551\u201378.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"491_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0092-8674(02)00676-1","volume":"108","author":"NK Cho","year":"2002","unstructured":"Cho NK, Keyes L, Johnson E, Heller J, Ryner L, Karim F, et al. Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell. 2002;108(6):865\u201376.","journal-title":"Cell"},{"issue":"7","key":"491_CR31","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.onc.1210709","volume":"27","author":"G Kurban","year":"2008","unstructured":"Kurban G, Duplan E, Ramlal N, Hudon V, Sado Y, Ninomiya Y, et al. Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2. Oncogene. 2008;27(7):1004\u201312.","journal-title":"Oncogene"},{"key":"491_CR32","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","volume":"1","author":"M Ohh","year":"1998","unstructured":"Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, et al. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell. 1998;1:959\u201368.","journal-title":"Mol Cell"},{"key":"491_CR33","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/onc.2009.35","volume":"28","author":"Y Guo","year":"2009","unstructured":"Guo Y, Schoell MC, Freeman RS. The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIM(EL). Oncogene. 2009;28:1864\u201374.","journal-title":"Oncogene"},{"key":"491_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2007.09.010","volume":"28","author":"H Yang","year":"2007","unstructured":"Yang H, Minamishima YA, Yan Q, Schlisio S, Ebert BL, Zhang X, et al. pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell. 2007;28:15\u201327.","journal-title":"Mol Cell"},{"key":"491_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ncb899","volume":"5","author":"A Hergovich","year":"2003","unstructured":"Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W. Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol. 2003;5:64\u201370.","journal-title":"Nat Cell Biol"},{"key":"491_CR43","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1021\/la9002065","volume":"25","author":"CH Chen","year":"2009","unstructured":"Chen CH, Terentjev EM. Aging and metastability of monoglycerides in hydrophobic solutions. Langmuir: the ACS journal of surfaces and colloids. 2009;25:6717\u201324.","journal-title":"Langmuir: the ACS journal of surfaces and colloids"},{"key":"491_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpc.2006.12.007","volume":"127","author":"T Arakawa","year":"2007","unstructured":"Arakawa T, Ejima D, Tsumoto K, Obeyama N, Tanaka Y, Kita Y, et al. Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. Biophys Chem. 2007;127:1\u20138.","journal-title":"Biophys Chem"},{"key":"491_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1177\/1087057112436557","volume":"17","author":"Z Ding","year":"2012","unstructured":"Ding Z, German P, Bai S, Feng Z, Gao M, Si W, et al. Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis. J Biomol Screen. 2012;17:572\u201380.","journal-title":"J Biomol Screen"},{"key":"491_CR38","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature00767","volume":"417","author":"WC Hon","year":"2002","unstructured":"Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW, et al. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature. 2002;417:975\u20138.","journal-title":"Nature"},{"key":"491_CR39","doi-asserted-by":"publisher","first-page":"2587S","DOI":"10.3945\/jn.116.234740","volume":"146","author":"CJ McNeal","year":"2016","unstructured":"McNeal CJ, Meininger CJ, Reddy D, Wilborn CD, Wu G. Safety and effectiveness of arginine in adults. J Nutr. 2016;146:2587S\u201393S.","journal-title":"J Nutr"},{"key":"491_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1742-7843.2005.pto_973110.x","volume":"97","author":"E Navarro","year":"2005","unstructured":"Navarro E, Alonso SJ, Martin FA, Castellano MA. Toxicological and pharmacological effects of D-arginine. Basic Clin Pharmacol Toxicol. 2005;97:149\u201354.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"491_CR41","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1534\/genetics.166.4.1775","volume":"166","author":"AC Groth","year":"2004","unstructured":"Groth AC, Fish M, Nusse R, Calos MP. Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics. 2004;166:1775\u201382.","journal-title":"Genetics"},{"key":"491_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/BJ20050675","volume":"393","author":"N Arquier","year":"2006","unstructured":"Arquier N, Vigne P, Duplan E, Hsu T, Therond PP, Frelin C, et al. Analysis of the hypoxia-sensing pathway in Drosophila melanogaster. Biochem J. 2006;393:471\u201380.","journal-title":"Biochem J"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0491-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0491-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:39Z","timestamp":1684617219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0491-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["491"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0491-x","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}